4.5 (757) · $ 21.99 · In stock
Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
Two cancer research studies reveal essential role of neutrophils
Patients with refractory metastatic colorectal cancer experience
AIRE polymorphism, melanoma antigen-specific T cell immunity, and
Tiago Biachi no LinkedIn: Two cancer research studies reveal
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of
A molecular glue to overcome cancer drug resistance? - ecancer
Scientists uncover a startling and exploitable coordination of
ASCO GI: Trifluridine/tipiracil plus bevacizumab improves OS for
Results from the TAGS study demonstrate safety and efficacy of
MicroRNA specifically kills cancer cells with common mutation
Surprise Finding Shows That Neutrophils Can Be Key Antitumor
Cancer discovery could revive failed treatments for solid tumours
Phase 2 trial data shows durvalumab immunotherapy with standard
ASCO GI: Less chemotherapy may have more benefit in rectal cancer